Amgen Inc (AMGN · NASDAQ)
AMGN · MARKET VIEW
Market view · as of Aug 31, 2026
Revenue (TTM)
$38.09B
+9.5% YoY
Gross margin
71.9%
EPS (latest q)
$6.29
vs $5.60 est · beat
52-wk position
93.7%
-2.6% vs 52w high · +12.9% 1mo
Price (last ~year)
Amgen Inc. (AMGN) reported Q2 2026 revenue of $10.05 billion, marking four consecutive quarters of earnings beats with a reported $6.29 EPS against a $5.60 estimate. The stock has appreciated 28.6% over the last three months to $432.42, reflecting a $233.78 billion market capitalization. The company posted a 9.5% year-over-year revenue increase and 64.9% earnings growth alongside a 35.5% operating margin, while recent filings indicate ongoing institutional investment activity.
Valuation
- Market cap
- $233.78B
- P/E
- 27.18
- PEG
- 2.294
- P/B
- 20.21
- P/S
- 6.14
- EV/EBITDA
- 15.86
- Beta
- 0.413
- Analyst target
- $388.48
Quality & returns
- Gross margin
- 71.9%
- Operating margin
- 35.5%
- Profit margin
- 23.0%
- ROE
- 91.5%
- ROA
- 8.7%
Price movement
- Last
- $432.42
- 1-month
- +12.9%
- 3-month
- +28.6%
- RSI (14)
- 63
- vs SMA200
- +23.0%
- 52-wk position
- 93.7% -2.6% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $10.05B | $3.51B | $2.38B | $3.44B |
| 2026-03-31 | $8.62B | $2.67B | $1.82B | $3.86B |
| 2025-12-31 | $9.90B | $3.94B | $1.33B | $3.30B |
| 2025-09-30 | $9.56B | $2.53B | $3.22B | $5.91B |
Recent news
- Somewhat-Bullish Pure Financial Advisors LLC Makes New $2.89 Million Investment in Amgen Inc. $AMGN · 2026-08-27
- Somewhat-Bullish Perennial Investment Advisors LLC Purchases Shares of 3,096 Amgen Inc. $AMGN · 2026-08-27
- Somewhat-Bullish Palogic Value Management L.P. Takes Position in Amgen Inc. $AMGN · 2026-08-27
- Neutral Parvin Asset Management LLC Invests $2.04 Million in Amgen Inc. $AMGN · 2026-08-27
- Neutral Amgen Inc. $AMGN Shares Sold by Strive Financial Group LLC · 2026-08-27
- Somewhat-Bullish Stonebridge Capital Management Inc. Acquires New Stake in Amgen Inc. $AMGN · 2026-08-27
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)